View Post

Chemotherapy linked to physical decline in older women with high-risk breast cancer

In In The News by Barbara Jacoby

Source: University of California – Los Angeles Health Sciences From: news-medical.net A UCLA-led study suggests women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function. The study, published in a special issue of the Journal of Cancer Survivorship, found over 30% of older …

View Post

Aspirin Provides No Benefit for Breast Cancer Recurrence, Survival

In In The News by Barbara Jacoby

By: Lori Solomon From: healthday.com Among participants with high-risk nonmetastatic breast cancer, daily aspirin use did not improve the risk for breast cancer recurrence or survival in early follow-up, according to a study published online April 29 in the Journal of the American Medical Association. Wendy Y. Chen, M.D., from the Dana-Farber Cancer Institute in Boston, and colleagues evaluated whether aspirin …

View Post

Mammography Study: AI Software Predicts One-Third of Breast Cancer Cases Up to Two Years Prior to Diagnosis

In In The News by Barbara Jacoby

By: Jeff Hall From: diagnosticimaging.com Emerging research suggests that adjunctive use of artificial intelligence (AI) in mammography screening accurately identifies high malignancy risk up to two years prior to diagnosis in over a third of women with screen-detected or interval cancers. For the retrospective study, recently published in Radiology, researchers evaluated the use of the adjunctive AI software Transpara version …

View Post

What Does “High Risk” for Breast Cancer Mean?

In In The News by Barbara Jacoby

From: healthline.com Breast cancer happens when cells in the breast begin to grow and divide out of control. Aside from some types of skin cancers, it’s the most common cancer affecting women in the United States. According to the American Cancer Society (ACS)Trusted Source, a woman’s average lifetime risk of developing breast cancer is about 13 percent. This translates to …

View Post

What Does “High Risk” for Breast Cancer Mean?

In In The News by Barbara Jacoby

From: healthline.com Breast cancer happens when cells in the breast begin to grow and divide out of control. Aside from some types of skin cancers, it’s the most common cancer affecting women in the United States. According to the American Cancer Society (ACS)Trusted Source, a woman’s average lifetime risk of developing breast cancer is about 13 percent. This translates to …

View Post

FDA Expands Abemaciclib Indication in HR+, Node+, High-Risk Breast Cancer

In In The News by Barbara Jacoby

By: Kristi Rosa From: onclive.com he FDA approved an expanded indication for abemaciclib (Verzenio) in combination with endocrine therapy for the adjuvant treatment of adult patients with hormone receptor–positive, HER2-negative, node-positive, early breast cancer that is at a high risk of recurrence. Now, those determined to be high risk who are eligible to receive the agent can be identified based …

View Post

Estrogen-blocking drugs reduce mortality rates in high-risk women

In In The News by Barbara Jacoby

From: medicalnewstoday.com In a recent study, researchers ran a computer model to reassess the lifetime benefits and potential harms of estrogen-blocking drugs for breast cancer prevention in women with high risk. Estrogen-blocking medication coupled with yearly screening lowers the risk of invasive breast cancer and death from breast cancer by 40% and 57% respectively, but may also cause a range …

View Post

Study confirms the unique danger of postpartum breast cancers

In In The News by Barbara Jacoby

By: Joe Rojas-Burke From: news.ohsu.edu A postpartum cancer diagnosis can move women who appear to have good prognosis into a high-risk category Breast cancers that emerge within five years of giving birth are more likely to spread and become deadly. Additionally, a new study shows that recent childbirth alone is an independent risk factor for breast cancer progression. The findings …

View Post

2 Years of Endocrine Therapy, 2 Decades of Protection From Metastatic Breast Cancer

In In The News by Barbara Jacoby

By: Charles Bankhead From: medpagetoday.com Tamoxifen protects low-risk premenopausal patients, goserelin helps high-risk patients Two years of adjuvant endocrine therapy for premenopausal breast cancer protected against metastatic recurrence for 20 years, a new analysis of a randomized trial showed. Premenopausal women who received goserelin, tamoxifen, or the combination had a 37%-51% reduction in the risk of distant recurrence versus no …

View Post

Cancer Patients at High Risk for Psychiatric Disorders, Suicide

In In The News by Barbara Jacoby

By: Mike Bassett From: medpagetoday.com One study finds risk doubled compared to the general population Cancer patients are at a particularly high risk of mental health disorders and suicide, two studies showed. In the first study, researchers found that cancer patients have nearly twice the risk of suicide compared with the general population, and about a 3.5 times greater risk …